Cargando…
Molecular genetics complexity impeding research progress in breast and ovarian cancers
Breast and ovarian cancer are heterogeneous diseases. While breast cancer accounts for 25% of cancers worldwide, ovarian cancer accounts for 3.5% of all cancers and it is considered to be the most lethal type of cancer among women. In Oman, breast cancer accounts for 25% and ovarian cancer for 4.5%...
Autores principales: | Gupta, Ishita, Burney, Ikram, Al-Moundhri, Mansour S., Tamimi, Yahya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492732/ https://www.ncbi.nlm.nih.gov/pubmed/28685067 http://dx.doi.org/10.3892/mco.2017.1275 |
Ejemplares similares
-
Epigenetic Status of FBXW7 Gene and Its Role in Ovarian Cancer Pathogenesis
por: Al Hinai, Meerah, et al.
Publicado: (2023) -
FAT4 silencing promotes epithelial-to-mesenchymal transition and invasion via regulation of YAP and β-catenin activity in ovarian cancer
por: Malgundkar, Shika Hanif, et al.
Publicado: (2020) -
Changing Trends of Breast Cancer Survival in Sultanate of Oman
por: Kumar, Shiyam, et al.
Publicado: (2011) -
Outcomes of Women with Non-Metastatic Triple-Negative Breast Cancer in Oman: A single-centre experience
por: Kumar, Shiyam, et al.
Publicado: (2019) -
Outcome of Omani Women with Breast Cancer-associated Brain Metastases Experience from a University Hospital
por: Zahid, Khawaja F., et al.
Publicado: (2019)